Paper Details

  1. Home
  2. Paper Details

[A comparative, well-controlled study of ceftizoxime suppository against ceftizoxime intravenous injection in infantile acute pneumonia].

Author: ArimasuO, FujiiR, HirumaF, HoriM, IwaiN, KunoK, MeguroH, SugitaM, TamuraK, ToyonagaY

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Ceftizoxime suppositories (CZX-S) were as effective as intravenous injections of ceftizoxime (CZX) in treating bacterial pneumonia in children. 97.1% of children treated with CZX-S recovered compared to 93.8% of children treated with CZX. CZX-S was well-tolerated with no significant side effects.
Paper Details　
Original Abstract of the Article :
We have attempted to clinically define the therapeutic usefulness of ceftizoxime suppository (CZX-S) in children with bacterial pneumonia, in a randomized trial. Intravenous injection of ceftizoxime (CZX) was used as the control. The results are summarized below. Subjects were inpatients with bacter...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3531567

データ提供：米国国立医学図書館（NLM）

Ceftizoxime: A New Route for Childhood Pneumonia

Childhood pneumonia is a serious threat to the health of young children. This research, like a dedicated physician searching for effective treatments for their young patients, compares the efficacy of ceftizoxime suppository (CZX-S) to intravenous ceftizoxime (CZX) in children with bacterial pneumonia. This study, conducted with the care and precision of a seasoned camel caravan, seeks to find a more comfortable and convenient treatment option for these vulnerable patients.

A Gentle Path to Recovery

The study found that ceftizoxime suppository, like a soothing oasis in the desert, was as effective as intravenous ceftizoxime in treating childhood pneumonia. It's like discovering a new route through the desert, offering a more comfortable and efficient journey to recovery. The study also found that the suppository formulation was well-tolerated, with fewer side effects than the intravenous injection.

A Brighter Future for Young Patients

This research offers a promising new treatment option for children with bacterial pneumonia, potentially improving their recovery experience and minimizing the need for invasive procedures. It's like finding a hidden spring in the desert, offering a source of hope and healing for those who need it most.

Dr.Camel's Conclusion

This study underscores the potential benefits of ceftizoxime suppository as an effective and well-tolerated treatment option for childhood pneumonia. It's a reminder that innovation and ingenuity can lead to more comfortable and efficient treatments for our youngest patients.

Date :
  1. Date Completed 1986-10-30
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

3531567

DOI: Digital Object Identifier

3531567

Related Literature

Article Analysis
・Side Effects of cefotaxime injection
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.